Technological advancements in wearable devices and continuous glucose monitoring are transforming diabetes care by providing real-time glucose data and reducing the burden of frequent finger-prick testing. These innovations improve glycemic control, minimize fluctuations, and enhance patient engagement through automated alerts and trend analysis. Integration with mobile applications and cloud-based platforms enables personalized feedback, empowering users to make informed lifestyle and medication adjustments. Artificial intelligence further refines predictive analytics, identifying patterns that help prevent hypoglycemia and hyperglycemia. As sensor accuracy and affordability continue to improve, wearable glucose monitoring is expected to become a standard tool in diabetes self-management, promoting better long-term health outcomes.
Mahir Khalil Ibrahim Jallo
Gulf Medical University, Canada
Yong Xiao Wang
Albany Medical College, United States
F Buck Willis
University of Belize, Belize
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Paraskevi Theofilou
Hellenic Open University, Greece
Teji S Dhami
Boost your Health and Wellness, United StatesSubmit your abstract Today
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters ?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, University of Belize, Belize
Title : Serum fructosamine: A more accurate screening test than 3-hour OGTT for diagnosis of gestational diabetes
Sarah Exley, Broadlawns Medical Center, United States